4.7 Review

Histone methylation modifiers in cellular signaling pathways

期刊

CELLULAR AND MOLECULAR LIFE SCIENCES
卷 72, 期 23, 页码 4577-4592

出版社

SPRINGER BASEL AG
DOI: 10.1007/s00018-015-2023-y

关键词

Histone methylation; Histone methyltransferase; Histone demethylase; Oncogenic signaling; Tumor suppressor pathway

资金

  1. NIH [R01 GM095659, R01 CA157919]
  2. Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center
  3. Cancer Prevention and Research Institute of Texas [RP110183]
  4. Odyssey Program at MD Anderson Cancer Center

向作者/读者索取更多资源

Histone methyltransferases and demethylases epigenetically regulate gene expression by modifying histone methylation status in numerous cellular processes, including cell differentiation and proliferation. These modifiers also control methylation levels of various non-histone proteins, such as effector proteins that play critical roles in cellular signaling networks. Dysregulated histone methylation modifiers alter expression of oncogenes and tumor suppressor genes and change methylation states of effector proteins, frequently resulting in aberrant cellular signaling cascades and cellular transformation. In this review, we summarize the role of histone methylation modifiers in regulating the following signaling pathways: NF-kappa B, RAS/RAF/MEK/MAPK, PI3K/Akt, Wnt/beta-catenin, p53, and ER alpha.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据